Tartu Biotehnoloogia Pargi tiim soovib teile ilusaid jõulupühasid!

Tartu Biotehnoloogia Pargi tiim soovib teile turvalisi ja rõõmsaid pühi ning inspireerivat ja tegusat uut aastat! 🎄🎁 🎄
 
 

Public Health Data Bootcamp salvestised on nüüd järelvaadatavad

10. – 14 detsembril 2020 toimus Biotehnoloogia Pargis EIT Healthi toel digitaalne terviseandmete Bootcamp. Üritusel tutvustati mitmeid Euroopa biopankasid ja terviseandmete registreid ning räägiti lähemalt, millistele terviseandmetele mil moel on võimalik ligi pääseda ning mis otstarbel antud andmeid kasutada.

Vaata ürituse salvestisi (inglisekeelsed) allpool.

___________________________________________________________________________________________________________
 

Terviseandmete kasutamine ettevõtluses / Lars Linsköld Med.Dr. (Portfolio manager, Sweper/ Swelife, Senior advisor AI.se, Regional developer Officier healthcare digitalization, Region Västra Götaland)

___________________________________________________________________________________________________________
 
Terviseregistrite ja biopankade tutvustused:

Estonian Biobank (EE) /Neeme Tõnisson, MD, PhD (Estonian Biobank, University of Tartu; Tartu University Hospital)

 
___________________________________________________________________________________________________________
 

Lifelines biobank (NL) / Ilse Broeders, MSc (Project manager Research office Lifelines Data and Biobank, The Netherlands)

 

___________________________________________________________________________________________________________

Biobank West (SE) / Elin Stenfeldt, MSc (Biobank West, Sahlgrenska University Hospital)

___________________________________________________________________________________________________________

SCAPIS (SE) / Göran Bergström

 

Paneel – VKEde ja terviseandmete registrite koostöö edulood

Panelistid:

Jaak Sarv, Geneto asutaja ja tegevjuht. Jaagul on 20-aastane tarkvaraarenduse ja andmeteaduse kogemus. Geneto on personaalmeditsiini ettevõte, mis aitab inimestel kaalust alla võtta ja vältida elustiili haigusi. Oma töös kasutavad nad polügeense riski skoore, mille on välja töötanud koos Tartu Ülikooli Eesti Geenivaramuga.

Neeme Tõnisson, MD, PhDTartu Ülikooli Eesti Biopanga uurimisgrupi juht, Tartu Ülikooli Kliinikumi kliiniline geneetik

Sven Parkel, PhD, ScanBalt peasekretär , Tartu Biotehnoloogia Pargi tegevjuht

Emil Syundyukov, PhDtervishoiu ja hariduse probleemide lahendamisele pühendunud arvutiteadlane. Paralleelselt akadeemilise kogemusega on varem asutanud ja töötanud mitmetes Startup ettevõtmistes ning viimased 2 aastat on ta Longenesise CTO.

Sachin Gaur (moderator), OInnovatioCuris tegevjuht, teadlane, kes on mobiilsete ja Interneti-lahenduste valdkonnas ettevõtja. Ta on seotud mitme ettevõtmisega digitaalse turunduse, mobiilsete lahenduste ja asjade Interneti valdkonnas.

 
 

Euroopa innovatsioonitsoon Indias (EIZI) pakub Euroopa innovaatoritele “pehmet maandumist” ja juurdepääsu India turule

Euroopa innovatsioonitsoon Indias (EIZI) on “pehme maandumise” kontaktpunkt Euroopast (ELi liikmesriigid ning ELi teadusuuringute ja innovatsiooni raamprogrammiga Horizon 2020 / Horizon Euroopa seotud riigid) tulevate idufirmade ja innovatsiooniga tegelevate ettevõtjate jaoks, kellele on Indias loodud tugeva infrastruktuuriga ja elujõulise ökosüsteemiga inkubaator ja kiirendi.

EIZI-l on määratud kontaktisik, kes „võtab vastu ja suunab“ Euroopa innovaatoreid, kes soovivad uurida India äri- ja ühisloome võimalusi. Teisisõnu on see platvorm, kus kontaktisik Indias juhatab Euroopa innovaatori India ökosüsteemi.

Inkubaatoril on võimekus pakkuda Euroopa innovaatoritele turule juurdepääsu teenuseid, mentoreid, korraldada üritusi, delegatsioonide külastusi ja üldise “pehme maandumise” India ökosüsteemi.

 

Lisateavet projekti ja EIZI teenuste kohta leiate SIIT.

Morning Health Talks Tartu 2 kohvihommikul tutvustati inimkeskse integreeritud haiglasüsteemi arenduse projekti

Morning Health Talks Tartu ürituste sarja teine kohvihommik toimus 19. novembril, kus Dr. Jaanus Pikani (Tartu Biotehnoloogia Park; MTÜ ScanBalt) ja Prof. Peeter Ross (TalTech, Tervisetehnoloogiate instituut; Ida-Tallinna Keskhaigla) esitlesid inimkeskse integreeritud haiglasüsteemi arenduse projekti (PERSON-CENTRED INTEGRATED HOSPITAL MASTER PLAN IN ESTONIA) esimese etapi tulemusi.

Projekti läbi viimist  alustas EV Sotsiaalministeeriumi taotlusel Euroopa Komisjoni Struktuurireformide Toetusteenistus (SRSS, uue nimega DG REFORM) 2020.a alguses. Praegune kaheaastase kestvusega projekt on ette nähtud neljaetapilisena, millest esimese – haiglate inimressursi, infrastruktuuri, finantsilise jätkusuutlikkuse, juhtimise ning andmete registreerimise ja infoliikumise kaardistus – tulemusi kohvihommikul esitletigi.

Ettekannetes toodi oskuslikult välja mahuka raporti kõige olulisemad ja huvitavamad aspektid. Üritust väisas üle viiekümne Eesti tervishoiu valdkonna eksperdi.

Morning Health Talks kohvihommikute eesmärk on inspireerida, vahendada olulisi, aktuaalseid ja innovaatilisi tervisevaldkonna uudiseid, ideid ja praktikaid ning tuua kokku Eesti tervisevaldkonna ökosüsteemi olulised mõjutajad ning tugevdada nendevahelist kommunikatsiooni.

MHT ürituste sarja esimene kohvihommik toimus 23. Septembril, kui Monika Toth (EIT Health InnoStars RIS programm), Taavi Annus (Sotsiaalministeerium) ja Simmo Saar (Terviseamet) arutlesid kommunikatsiooni, innovatsiooni ja koostöö rakendamise aspektide üle tervisevaldkonnas.

>>> MHT Tartu esitluse slaidid<<<

CATALYST EUROPE – looking for talents for the online workshop

We are looking for researchers, PhD students, postdocs who are active in healthcare IT, biotech or medtech fields, and those business people who lead institutions that work with such professionals to join the Catalyst Europe online workshop. Workshop takes place on December 8 and 9.

>>>Apply HERE<<<

Catalyst Europe - Researching impact_Invitation letter_registration

Tartu BioInnovation Day 2020 focused on hacking innovative cross-cutting solutions in the fields of health, food and biotechnology

On October 24 the Tartu Bioinnovation Day took place for the third time, bringing together eight teams of university students from different Estonian universities and institutes to hack solutions in the fields of health and wellbeing, biosustainability and nutrition. Multidisciplinary teams of 2-6 spent the day guided by facilitators and mentors, validating their ideas and networking.  The day ended with presentations by the teams, where the two winners – MycoCycle and Xylitol – were chosen to represent Estonia in the 2020 EIT Health Innovation Days European finals.

Between 25th September and 25th November 2020, partners from 5 EIT Health Co-Location Centres and 13 RIS Hubs host their own i-Days at 31 locations around Europe, online and in-person.

 

The day commenced with inspirational speeches by Katrin Krõlov from Selfdiagnostics, Liina Vaher from Civitta, as well 2019 winner Nikita Umov from the University of Tartu Faculty of Medicine. In the beginning of the hackathon, eight teams were formed to tackle cross-cutting real life challenges in the field of health, food and wider biotechnology. During the day, coach Kalev Kaarna introduced participants to practical tools in design thinking and Harald Lepisk prepared the participants for pitching their ideas. The presentations got feedback from a panel of experts, representing both the health sector as well as business development competences. All teams made good progress with their idea, despite what was their starting point. The day concluded with presentations on further opportunities in EIT Health by Merike Leego and in EIT Food by Justin Hein.

Although all participants won new friends and knowledge, there were also several special prizes. The teams that won the opportunity to represent Estonia in the 2020 EIT Health Innovation Days European finals were MycoCycle and Xylitol. 

The team MycoCycle proposed the solution to grow specific mushrooms on the used coffee grounds, with the possibility to extract compounds that can cure Alzheimer’s disease. MycoCycle won a chance to represent Estonia in the EIT Health Innovation Days European finals together with a 600 EUR cash prize from EIT Health provided by Tartu Biotechnology Park, an EIT Health Hub. Team also won BioCC-s Professional Food Product Development Coaching. 

The team Xylitol also won the place in the European finals, as well as a cash prize of 400 EUR from EIT Health provided by Tartu Biotechnology Park. Their solution tackled two problems at the same time – the xylitol users (people with diabetes or struggling with obesity) on the one side, and the valorization of wooden biomass on the other. The idea is based on the technologies that the students work on in the University of Tartu, an EIT Health partner. The smaller prizes included sTARTUp Day Tickets which were given out by Civitta and Tartu Biotechnology Park, scientific and business consultations.

Tartu BioInnovation Day 2020 that took place at the new Delta building in Tartu brought together students, researchers, start-ups, mentors, coaches and speakers from all over Estonia. Participants can use the new tools and skills to continue to work on the idea, or use the experience from the hackathon to start working on new challenges. In the words of the organizer Liina Joller-Vahter “the hackathon is just the beginning, once you learn the quick idea validation skills, you can use them most anywhere”.

Tartu Biotechnology Park and University of Tartu want to thank all the participants, contributors and facilitators and are already looking for the Tartu BioInnovation Days 2021!

The main supporters of the Tartu BioInnovation Days 2020 were EIT Health and EIT Food. Full list of contributing organisations and partners can be seen at www.bioinnovationdays.ee.

To stay up to date with EIT Health and other bio- and health technology news, follow the FB page of Tartu Biotechnology Park: https://www.facebook.com/tartubiotehnoloogiapark/

To keep up to date with UT Faculty of Economics events, publications and other activities, follow the UT Faculty of Economics FB page: https://www.facebook.com/UniTartuEconomics/ and UT Ecoinnovation Club page: https://www.facebook.com/ecotartu 

EIT Health Innostars FB page: https://www.facebook.com/EITHealthInnoStars/

EIT Health FB page: https://www.facebook.com/EITHealth/

EIT Health website: https://eithealth.eu/

Avatud on uus konkurss – EIT Health RIS Innovation Call 2021

  • EIT Health korraldab juba kolmandat aastat järjest RIS Innovation Call konkurssi, mille eesmärk on toetada paljutõotavaid ja innovatiivseid tervishoiuprojekte.
  • RIS Innovation Calli kaudu sai rahastust ka Eesti ettevõte DocuMental, 2019. ja 2020. aastal on programmi raames panustatud 30 Euroopa tervishoiuinnovaatori arengusse kokku 3 miljonit eurot.

EIT Healthi iga-aastase RIS Innovation Call konkursi eesmärk on toetada arenevate Kesk-, Ida- ja Lõuna-Euroopa piirkondade tervishoiuvaldkonna innovaatoreid, sealhulgas ka lootustandvaid Eesti iduettevõtteid. Konkursi tulemusena saab iga väljavalitud projekt oma uuendusliku lahenduse arendamiseks rahastust, nõustamist ning kontaktiloomise võimalusi Euroopa tervishoiu tipptegijatega.

EIT Health RIS Innovation Calli eesmärk on rahastada kohalike akadeemiliste institutsioonide ning uuringurühmade kvaliteetseid, suutlikke ning tasakaalustatud projekte. Projekte arendatakse koostöös EIT Healthi keskustega – kohalike organisatsioonidega, kes toetavad piirkondlike ökosüsteemide arenemist.

Taotluste vastuvõtt kuni 15. novembrini 2020 läbi Optimy platvormi

Lisateave, konkursikutse  ja täiendatavad dokumendid on leitavad EIT Health RIS Innovation Call 2021 veebisaidil: https://eithealth.eu/opportunity/eit-health-ris-innovation-call-2021/

Kõik konkursiga seotud küsimused palume esitada EIT Health Innostars kesksele meiliaadressile:  

Teadlaste Öö Festival Tartu Biotehnoloogia Pargis – seminari salvestis nüüd järelvaadatav!

24. septembril korraldasime Teadlaste Öö Festival 2020 raames digitaalse lühiseminari kahe teadlasega teemade kohta, mis meid ühel või teisel moel puudutavad.
 
⚡️ Ökotoksikoloog, teadusajakirjanik ja teaduse populariseerija Randel Kreitsberg avas kuulajatele mikroplasti maailma ning tutvustas värsket Läänemere olukorra- ning mikroplasti teadusuuringut.
⚡️Teine teema on aga iga inimest hoopis isiklikumal tasandil puudutav immuunsuse teema, mida immunoloog Pärt Peterson esitas seekord läbi hetkel väga aktuaalse Covid-19 prisma.
 
Vaata seminari salvestist:
 

 

3rd BIC webinar delivered successfully, recording now available!

Third and final BIC project webinar successfully delivered! More than 60 participants attended the second BIC webinar on “How to Commercialise your Biomarker Discovery” on September 22, 2020.

In this final webinar Valerie Daussin Laurent, the project leader of the BIC consortium, introduced the viewer to the BIC tools, in particular the BIC Guide, which is a web-based tool that supports academic researchers and SMEs when developing an in-vitro diagnostic biomarker invention to a commercial product.

The BIC Consortium is proud to present the results of the BIC project, a set of support tools for researchers, technology transfer offices and SMEs for a better and more successful commercialisation of biomarkers inventions. BIC tools conduct and guide the user through the discovery and innovative process, integrating not only technical and clinical task but also commercial and regulatory considerations.

The tools are available at: bicguide.biomarker.nu

With this final webinar we conclude our webinar series on how to commercialize your biomarker discovery. The series has been very successful with participants attending from all over the world. Attendees ranged from senior researchers and PhD students to managing directors, R&D directors and business development managers of SMEs and large companies.

Webinar topic:

Launching the Support Tool for Biomarker Commercialization (presentation available for download)

Valerie Daussin Laurent, Team Leader Business Development, Aalborg University Hospital, Project Leader BIC consortium

Moderator:Teppo Laaksonen, Network Manager, Turku Science Park Ltd

Muudatus! Eesti Inimesegeneetika Ühingu aastakonverents 19.11.20 toimub digitaalsena

Head Eesti Inimesegeneetika Ühing annab teada, et Eesti InimeseGeneetika Ühingu aastakonverents toimub sel aastal 19. novembril videosilla vahendusel!

Konverentsil osalemine on tasuta.

Viide videosillale saadetakse registreerunuile e-kirjaga, see on huvilistele kättesaadav nii kodulehel kui ka ühingu Facebook lehel. Konverentsiks kasutatakse Zoom keskkonda. Täpsem info ning link tehakse kättesaadavaks enne konverentsi algust.  

Veebiülekande kvaliteedi tagamiseks palutakse kõigil huvilistel end konverentsile registreeruda.

Konverentsile saate registreeruda SIIN: https://docs.google.com/forms/d/1Dl2eDU91zNRNRA6vGxDNescSQJC8arviw9sFfmfofuk/edit

 

Eesti Inimesegeneetika Ühing koondab geneetika, genoomika, geenitehnoloogia ja nende siduserialade teadlasi, eksperte, ettevõtjaid, meedikuid, tudengeid jne. Iga-aastane ühingu konverents on selle kogukonna kõige olulisem teadusfoorum Eestis. Konverentsi aastatepikkune edu on tinginud selle laiapõhjaline kaasav programm ja eestikeelne formaat. Teretulnud on kõik, kel on geneetika valdkonnaga ametialane kokkupuude või lihtsalt huvi geneetika vastu.

Konverentsi programm:

EstSHG_online_programm

Second BIC Webinar successfully delivered!

Second BIC Webinar successfully delivered! More than 70 participants attended the second BIC webinar on “How to Commercialise your Biomarker Discovery” on August 27, 2020.

This webinar went into more detail about the Biomarker Commercialization project with the focus on European IVD Regulation with a speaker from the Finnish Medicines Agency FIMEA.

The webinar dived into the regulatory requirements for biomarker development and commercialization, an important know-how for any research group, SME or TTO working with biomarker development.

The IVD regulation is also covered in detail in the Biomarker Commercialization (BIC) toolset, designed to support, step-by-step, both academic researchers and SMEs when developing a biomarker-based invention to a commercial product. The BIC toolset includes a Biomarker Commercialization Guide, which covers technical, clinical, commercial and regulatory aspects, a Best Practices Handbook based on experiences from TTOs in the field, and a review tool for TTOs and a Guide for Regulatory Process. The toolset has been created in the BIC project funded by Interreg Baltic Sea Region Programme, and it will be available for free in summer 2020. 

 Webinar programme:

  • Introduction to European IVD regulation – requirements for biomarker product development and commercialization (Nelli Karhu, Finnish Medicines Agency FIMEA)
  • Q&A  
  • Moderator: Teppo Laaksonen, Network Manager, Turku Science Park Ltd

We are happy to announce that the Best Practices and Pitfalls in Commercializing IVD-Applicable Biomarkers Handbook is now available from biomarker.nu webpage.

Download the ebook here or learn more about the Handbook at the BIC homepage HERE.

Join EIT Health online Mobility and Active Ageing Summer School

The Summer School in Mobility and Active Ageing aims to train professionals to design, develop, and implement support, or health and functional independence promotion solutions for persons with reduced mobility or at risk of mobility reduction, when carrying out their daily activities.

The curriculum is designed to provide the learners with skills viewing the promotion of Mobility and Active Ageing, considering different conditions related with health, disability, and ageing, through solutions based on policies, services, or products.

The online course is organized in 8 modules (70 hours), divided into theoretical sessions (with tutorial) and practical sessions / challenges (with mentoring).

The course aims to train learners from different professional fields:

  • To screen for frailty, falls and mobility limitations in older adults and other adults with clinical conditions and to select the best strategies/interventions to prevent Mobility and Active Ageing.
  • To empower learners by preparing them with the knowledge, skills, and values necessary to participate in research-related decision making and to contribute with solutions to social challenges.

Applications to the Summer School will run until 25th June.

The application fee of 150€ includes the online course, the certificate and the e-book in Mobility and Active Ageing (course contents).

The Summer School awards a certificate to students who successfully complete online course provided they do not exceed the maximum number of absences.
The complete course will correspond to 6 ECTS.

Find out more: http://formesp.fmh.ulisboa.pt/summer-school-mobility-active-ageing/en

BIC Webinar on “How to Commercialise your Biomarker Discovery” is now available online!

Yesterday, on June 3, 2020, the first part of the BIC Webinar series was successfully held! 78 participants from all over the world attended the first BIC webinar on “How to Commercialise your Biomarker Discovery”.

 

The webinar focused on the biomarker commercialization process and the biomarker commercialization guide.
The BIC guide covers technical, clinical, commercial and regulatory aspects, and it is designed to support, step-by-step, both academic researchers and SMEs when developing a Biomarker based invention into a commercial product.
Other tools created during the project will be:
-> Best Practices Handbook based on experiences from TTOs in the field
-> Review tool for TTOs
-> Guide for Regulatory Process

Webinar presentations:

Valerie Daussin Laurent is a business developer at Aalborg University Hospital in Denmark. She has 20 years of experience within innovation, patenting and technology transfer. With a background as a legal adviser in Intellectual Property Rights, she assists researchers from the hospital from discovery to the industrial phase. The support includes patenting, fundraising as well as business development and negotiation with the partners. For the last 2 years, she has been project leader for the BIC consortium.

  • “SME experience with BIC Guide”
    Huram Konjen, CEO of Dianox

Huram Konjen is the CEO of Dianox, a biotechnology company developing diagnostics for infectious diseases. Huram has a master’s degree in Digital Innovation and Management and previously worked at Deloitte as a Management Consultant, where he facilitated innovation labs for companies wanting to develop sustainable products.

Moderator: Teppo Laaksonen

Teppo Laaksonen is a Network Manager at HealthTurku cluster, Turku Science Park Ltd. He has 30 years of experience in the diagnostic industry, in large companies and SMEs. His responsibilities included quality systems, regulatory affairs of medical devices, SME funding, development of platform technology, international marketing, sales and cooperation, and has know-how related to IVD markets and trends. In regard to biomarker commercialization he has knowledge on biomarker registration, quality assurance policy, product development, and upscaling of production.

 

*BIC is an Interreg program in the Baltic Sea Region that develops support tools for researchers, technology transfer offices and SMEs for better and more successful commercialisation of biomarkers inventions. The current results of the BIC project is a set of tools that conduct and guide the user through the discovery and innovative process, integrating not only technical and clinical task but also commercial and regulatory considerations.For more information on biomarker commercialization visit the project’s website: biomarker.nu

Neljapäeval, 30.aprill toimus veebiseminar “Bioplastics and circular economy”

Neljapäeval, 30.aprill toimus eelkõige ettevõtjatele suunatud veebiseminar “Bioplastics and circular economy”
Plastikpakenditesse pakendamine aitab säilitada toodete algseid omadusi, aga kuidas seda teha nii, et pakendi keskkonnamõju oleks väiksem? Seminaril sai hea ülevaate erinevate plastpakendi liikide omadustest, kasutusvõimalustest ja keskkonnamõjudest. Räägiti nii plastiku ringmajanduse soodustamisest kui vetikatest toodetud jäigast (Rootsi) ning suhkruroo jääkidest toodetud painduvast (Eesti) plastikust.

Veebiseminari ettekanded olid järgnevad:

  • Dr. M. Kriipsalu (Eesti Maaülikool) annab ülevaate erinevatest plastikutest, nende omadustest ning mõjust keskkonnale. Samuti avab tausta, kuidas mõni plastik soodustab ja teine takistab ringmajandust.
  • Dr. Dr. F. Gröndahl (KTH Royal Institute of Technology, Rootsi) Töötab asutuses, kus toodetakse vetikatest jäiku plastikpakendeid. Räägib tootmisest ning nende toodete iseloomust.
  • T. Paara (Estiko-Plastar AS) Töötab ettevõttes, kus toodetakse bioloogilisel toorainel põhinevat elastset plastikust pakendeid. Ringmajanduse soodustamine.

Vaata veebiseminari järele siin:

EIT Health Community is tackling COVID-19 related crisis with several initiatives

The EIT Health community is working tirelessly in response to the pandemic, harnessing their combined knowledge and the strength of their network to join the fight against the virus.

The EIT Health teams working across 25 countries are also supporting the community in raising awareness of the European Union’s newly launched COVID-19 initiatives such as the Joint Procurement Agreement for purchasing personal protective equipment, respiratory ventilators and items necessary for coronavirus testing and the rescEU stockpile of supplies needed to fight the coronavirus.

Several organisations in the EIT Health community are directly engaged in the crisis response, from the development of critical medical equipment, potential vaccines and treatment to remote monitoring and patient support and donation of emergency supplies. They are posting the latest examples of  innovative solutions being developed and rolled out across the EIT Health network here: https://eithealth.eu/covid-19-community-response/

EIT Health has also launched a new ‘matchmaking’ solution that allows innovators working in COVID-19-related research, product development, or frontline healthcare to share their on the ground needs and solutions. They have already received offers and asks ranging across software design support, home monitoring solutions and decontamination services, and are currently working through them to create the best matches possible.